Bluejay Diagnostics Inc (BJDX)

$1.07 +0.08 (8.39%)
Market Cap 1.02M
Revenue (ttm) 0.00
Net Income (ttm) -6.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 759,400
Avg Vol 7,378,860
Day's Range N/A - N/A
Shares Out 1.04M
Stochastic %K 28%
Beta 0.89
Analysts Strong Buy
Price Target $32.00

Company Profile

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests fo...

Industry: Medical Devices
Sector: Healthcare
Phone: 844 327 7078
Address:
360 Massachusetts Avenue, Suite 203, Acton, United States
INEEDMONEY87
INEEDMONEY87 Aug. 12 at 3:09 AM
$BJDX
0 · Reply
BankingBig
BankingBig Aug. 11 at 9:07 PM
$BJDX I'll take buck 50 tomorrow!
0 · Reply
sndbnd
sndbnd Aug. 11 at 7:52 PM
$BJDX close above 1.11 will be highly bullish
0 · Reply
sndbnd
sndbnd Aug. 11 at 7:43 PM
$BJDX someone's buying before close. Volume slowly picking up , not drastic.
0 · Reply
Putnik
Putnik Aug. 11 at 6:51 PM
$BJDX hope this explodes AH
0 · Reply
Gojomojo
Gojomojo Aug. 11 at 6:09 PM
$BJDX alright enough is enough! Lets see $2+
1 · Reply
AtariLynx
AtariLynx Aug. 11 at 6:04 PM
$BJDX lower? It’s going into space!
1 · Reply
PierreleRat
PierreleRat Aug. 11 at 4:57 PM
$BJDX lower please 🙏
0 · Reply
Putnik
Putnik Aug. 11 at 12:25 PM
$BJDX started a little at $1 this moves quick traded it 2 times last year and made $$ let’s make this 3rd pt 1.35 to 1.50
0 · Reply
BankingBig
BankingBig Aug. 11 at 11:58 AM
$BJDX loaded some shares here at .98 overnight. Like this price for a quick turnaround.
0 · Reply
Latest News on BJDX
Bluejay Diagnostics completes enrollment in SYMON-II study

2026-07-21T10:35:18.000Z - 21 days ago

Bluejay Diagnostics completes enrollment in SYMON-II study

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Jul 21, 2026, 6:30 AM EDT - 21 days ago

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Bluejay Diagnostics files to sell 11.22M shares of common stock for holders

2026-06-17T21:25:09.000Z - 7 weeks ago

Bluejay Diagnostics files to sell 11.22M shares of common stock for holders

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Jun 5, 2026, 8:13 PM EDT - 2 months ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Jun 2, 2026, 12:19 PM EDT - 2 months ago

Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Why Is Penny Stock Bluejay Diagnostics (BJDX) Up Today?

2026-06-02T13:13:16.000Z - 2 months ago

Why Is Penny Stock Bluejay Diagnostics (BJDX) Up Today?

Bluejay Diagnostics, Argonaut Manufacturing Services announce partnership

2026-06-02T10:45:59.000Z - 2 months ago

Bluejay Diagnostics, Argonaut Manufacturing Services announce partnership

Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership

Jun 2, 2026, 6:30 AM EDT - 2 months ago

Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership

Bluejay Diagnostics Provides First Quarter 2026 Corporate Update

May 7, 2026, 4:01 PM EDT - 3 months ago

Bluejay Diagnostics Provides First Quarter 2026 Corporate Update

Bluejay Diagnostics reaches 624 patient enrollment in Symphony clinical trial

2026-04-07T10:45:34.000Z - 4 months ago

Bluejay Diagnostics reaches 624 patient enrollment in Symphony clinical trial

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

Apr 7, 2026, 6:30 AM EDT - 4 months ago

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Mar 12, 2026, 6:30 AM EDT - 5 months ago

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

NorthStrive Fund urges Bluejay to evaluate strategic opportunity

2026-03-11T13:35:11.000Z - 5 months ago

NorthStrive Fund urges Bluejay to evaluate strategic opportunity

NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics

Mar 11, 2026, 9:29 AM EDT - 5 months ago

NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics

Bluejay Diagnostics says SYMON II study ‘progressing as planned’

2026-03-06T11:41:51.000Z - 5 months ago

Bluejay Diagnostics says SYMON II study ‘progressing as planned’

Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

Feb 20, 2026, 6:30 AM EST - 6 months ago

Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

Bluejay Diagnostics enrolls 545 patients in SYMON II study

2026-02-17T11:45:15.000Z - 6 months ago

Bluejay Diagnostics enrolls 545 patients in SYMON II study

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

Feb 17, 2026, 6:30 AM EST - 6 months ago

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

Bluejay Diagnostics Inc trading halted, news pending

2026-01-29T00:50:10.000Z - 6 months ago

Bluejay Diagnostics Inc trading halted, news pending

Bluejay Diagnostics announces 1-for-4 reverse stock split

2026-01-27T13:10:41.000Z - 7 months ago

Bluejay Diagnostics announces 1-for-4 reverse stock split

Bluejay Diagnostics completes commercial-scale IL-6 antibody production

2025-12-29T12:05:14.000Z - 8 months ago

Bluejay Diagnostics completes commercial-scale IL-6 antibody production

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

Dec 29, 2025, 7:00 AM EST - 8 months ago

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

Bluejay Diagnostics provides Q3 corporate update

2025-11-10T12:55:58.000Z - 9 months ago

Bluejay Diagnostics provides Q3 corporate update

Bluejay Diagnostics files to sell 6.93M shares of common stock for holders

2025-10-23T21:05:24.000Z - 10 months ago

Bluejay Diagnostics files to sell 6.93M shares of common stock for holders

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Oct 10, 2025, 5:16 PM EDT - 10 months ago

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bluejay Diagnostics announces $4.5M private placement priced at-the-market

2025-10-09T19:20:15.000Z - 10 months ago

Bluejay Diagnostics announces $4.5M private placement priced at-the-market

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Oct 9, 2025, 3:15 PM EDT - 10 months ago

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Why Is Bluejay Diagnostics Stock (BJDX) Up 115% Today?

2025-10-09T12:11:30.000Z - 10 months ago

Why Is Bluejay Diagnostics Stock (BJDX) Up 115% Today?

Bluejay Diagnostics and SanyoSeiko expand partnership for Symphony platform

2025-10-09T10:35:27.000Z - 10 months ago

Bluejay Diagnostics and SanyoSeiko expand partnership for Symphony platform

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Oct 9, 2025, 6:30 AM EDT - 10 months ago

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Aug 7, 2025, 6:30 PM EDT - 1 year ago

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Bluejay Diagnostics provides corporate update, reduces headcount to five

2025-06-03T20:20:12.000Z - 1 year ago

Bluejay Diagnostics provides corporate update, reduces headcount to five

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Jun 3, 2025, 4:05 PM EDT - 1 year ago

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Bluejay Diagnostics files to sell 1.09M shares of common stock for holders

2025-04-29T21:35:15.000Z - 1 year ago

Bluejay Diagnostics files to sell 1.09M shares of common stock for holders

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Apr 15, 2025, 7:00 AM EDT - 1 year ago

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Apr 7, 2025, 5:21 PM EDT - 1 year ago

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Bluejay Diagnostics Announces Reverse Stock Split

Nov 13, 2024, 5:10 PM EST - 1 year ago

Bluejay Diagnostics Announces Reverse Stock Split

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Jun 28, 2024, 11:32 AM EDT - 2 years ago

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Jun 26, 2024, 8:00 AM EDT - 2 years ago

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Jan 2, 2024, 5:58 PM EST - 2 years ago

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Dec 28, 2023, 8:00 AM EST - 2 years ago

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Dec 27, 2023, 9:00 AM EST - 2 years ago

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 4:05 PM EST - 2 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 25, 2023, 8:00 AM EDT - 3 years ago

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Aug 16, 2023, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

May 19, 2023, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

May 10, 2023, 7:30 AM EDT - 3 years ago

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

Bluejay Diagnostics Reports 2022 Financial Results

Mar 20, 2023, 4:15 PM EDT - 3 years ago

Bluejay Diagnostics Reports 2022 Financial Results

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Feb 16, 2023, 8:00 AM EST - 3 years ago

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Nov 9, 2022, 8:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 30, 2022, 4:05 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Aug 16, 2022, 7:30 AM EDT - 4 years ago

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Jul 27, 2022, 7:30 AM EDT - 4 years ago

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Jul 26, 2022, 4:30 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Jul 6, 2022, 7:30 AM EDT - 4 years ago

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Apr 20, 2022, 4:10 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Mar 28, 2022, 7:00 AM EDT - 4 years ago

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Mar 24, 2022, 7:00 AM EDT - 4 years ago

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Mar 10, 2022, 7:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Jan 31, 2022, 7:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Jan 13, 2022, 11:29 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Jan 5, 2022, 8:15 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Dec 16, 2021, 9:11 AM EST - 5 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

Nov 10, 2021, 8:15 AM EST - 5 years ago

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

INEEDMONEY87
INEEDMONEY87 Aug. 12 at 3:09 AM
$BJDX
0 · Reply
BankingBig
BankingBig Aug. 11 at 9:07 PM
$BJDX I'll take buck 50 tomorrow!
0 · Reply
sndbnd
sndbnd Aug. 11 at 7:52 PM
$BJDX close above 1.11 will be highly bullish
0 · Reply
sndbnd
sndbnd Aug. 11 at 7:43 PM
$BJDX someone's buying before close. Volume slowly picking up , not drastic.
0 · Reply
Putnik
Putnik Aug. 11 at 6:51 PM
$BJDX hope this explodes AH
0 · Reply
Gojomojo
Gojomojo Aug. 11 at 6:09 PM
$BJDX alright enough is enough! Lets see $2+
1 · Reply
AtariLynx
AtariLynx Aug. 11 at 6:04 PM
$BJDX lower? It’s going into space!
1 · Reply
PierreleRat
PierreleRat Aug. 11 at 4:57 PM
$BJDX lower please 🙏
0 · Reply
Putnik
Putnik Aug. 11 at 12:25 PM
$BJDX started a little at $1 this moves quick traded it 2 times last year and made $$ let’s make this 3rd pt 1.35 to 1.50
0 · Reply
BankingBig
BankingBig Aug. 11 at 11:58 AM
$BJDX loaded some shares here at .98 overnight. Like this price for a quick turnaround.
0 · Reply
sndbnd
sndbnd Aug. 11 at 1:17 AM
$BJDX tomorrow is our day
1 · Reply
indepth1
indepth1 Aug. 10 at 8:21 PM
$BJDX
0 · Reply
HotBigCoins
HotBigCoins Aug. 10 at 3:40 PM
$BJDX just waiting to unload 22k shares at $3
2 · Reply
PierreleRat
PierreleRat Aug. 10 at 3:23 PM
$BJDX smart money is holding for lower to buy. Waiting for my sub $1 to fill
0 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 10 at 2:23 PM
$BJDX idk this feels like they are trying to make us bj dx.....really petering out here...
0 · Reply
Montpbm
Montpbm Aug. 10 at 1:02 PM
$BJDX $ZJYL We're definitely next
0 · Reply
Montpbm
Montpbm Aug. 10 at 12:58 PM
$BJDX Buying more here
0 · Reply
Gojomojo
Gojomojo Aug. 10 at 12:44 PM
$BJDX can this follow $ZJYL 🤔
1 · Reply
Zackpedia
Zackpedia Aug. 7 at 4:32 PM
$BJDX Down to 1, you could’ve…
0 · Reply
VDG1983
VDG1983 Aug. 7 at 4:08 PM
$BJDX as I said yday, dip below 1, Wait to 1.5-1.6 if break will sky high, will take few weeks though
0 · Reply
Spindr88
Spindr88 Aug. 7 at 3:47 PM
$BJDX really bad call on my part at 1.45 and all I can read on the chart is 💩. Not even a China dumpster and here we are. Good luck folks.
0 · Reply
Montpbm
Montpbm Aug. 7 at 1:18 PM
$BJDX Grab you some BJDX ASAP! Micro-float and will run soon. GET IN EARLY! $MB $NAMI $HCWC
0 · Reply